We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Physical Activity and Thrombophilic Risk Investigated

By LabMedica International staff writers
Posted on 18 Feb 2020
Print article
Image: The BCS XP System is one of the most widely used fully automated hemostasis analyzers, delivers accurate and precise results (Photo courtesy of Siemens Healthcare).
Image: The BCS XP System is one of the most widely used fully automated hemostasis analyzers, delivers accurate and precise results (Photo courtesy of Siemens Healthcare).
Among the effects of physical exercise on coagulation, the influence on protein anticoagulant system and PC deficiency-related thrombophilic risk are still controversial. The impact of physical activity on the coagulation system has been described.

Physical activity (PA) determines a shortening of the activated partial thromboplastin time (APTT) and an increase of the factor VIII. On the other hand, little is known about the variations of the anticoagulant determinants and specifically of Protein C (PC) system, during PA, and in the subsequent recovery phase.

Hematologists at the Ospedale Fatebenefratelli (Naples, Italy) and their colleagues analyzed the variations of the PC system in healthy subjects (12 males, age 18–43 years; mean: 28.5 ± 5.30) performing a treadmill procedure. They measured the APTT before and after activation of endogenous PC, in these subjects before and after a physical exercise and during the subsequent recovery phase (up to one hour). Protein C activity-dependent clotting time (PCAT) was measured on all blood samples by ProC Global test (Siemens Healthcare, Malvern, PA, USA). APTT was also assayed using Siemens Healthcare Pathromtin SL, with a BCS instrument.

The team reported that for the 20 participants in the study, APTT values decreased slightly, i.e., from a basal value of 37.5 seconds (35.0–42.0) to 34.0 seconds (31.0–39.3) and to 35.5 seconds (32.3–38.0) at 15 and at 30 minutes post-exercise respectively. On the other hand, the Pro C values progressively dropped from a median basal level of 123 seconds (114.7–152.3) to 84.5 seconds (78.3–91.0) at 30 minutes post-exercise and returned to baseline levels at 60 minutes.

The authors concluded that the their study shows that the coagulation unbalance observed after strenuous exercise and with no consequence in healthy individuals with normal PC level, could increase the thrombophilic risk in silent carriers of significant defects of the protein C system and occasionally trigger an episode of deep vein thrombosis. The study was published on January 30, 2020 in the Journal of Blood Medicine.

Related Links:
Ospedale Fatebenefratelli
Siemens Healthcare


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.